What ARS Pharmaceuticals SPRY segment performance reveals Q4 2025 Better Than Expected INGN Inogen delivers narrower than expected Q4 2025 loss shares dip 014 percent in todays trading The quiet positioning of Star Bulk SBLK nobody discusses Flirts with Breakout 20260503 Why Coda Octopus CODA could be the turning point youve been waiting for Edges Higher 20260506 VZLA Vizsla EPS beats by 44 but stock slides investors eye revenue generation timeline BZ Kanzhun reports narrow Q4 2025 EPS miss shares rise as investors look past minor underperformance VRM Vroom reports Q3 2025 earnings with no prior analyst consensus shares close unchanged today What Oxbridge OXBR does that makes it resilient 256 20260506